These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 35176907)

  • 1. COVID-19 and herd immunity.
    Ashton J
    J R Soc Med; 2022 Feb; 115(2):76-77. PubMed ID: 35176907
    [No Abstract]   [Full Text] [Related]  

  • 2. The long road.
    Cohen J
    Science; 2021 Feb; 371(6531):768-772. PubMed ID: 33602838
    [No Abstract]   [Full Text] [Related]  

  • 3. Could COVID-19 be contained in poor populations by herd immunity rather than by strategies designed for affluent societies or potential vaccine(s)?
    Ruppel A; Halim MI; Kikon R; Mohamed NS; Saebipour MR
    Glob Health Action; 2021 Jan; 14(1):1863129. PubMed ID: 33397199
    [No Abstract]   [Full Text] [Related]  

  • 4. Mix-and-match COVID vaccines: the case is growing, but questions remain.
    Lewis D
    Nature; 2021 Jul; 595(7867):344-345. PubMed ID: 34211168
    [No Abstract]   [Full Text] [Related]  

  • 5. Neutralizing SARS-CoV-2.
    Poeschla E
    Elife; 2020 Dec; 9():. PubMed ID: 33320086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 pandemic and vaccination build herd immunity.
    Redwan EM
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):577-579. PubMed ID: 33577008
    [No Abstract]   [Full Text] [Related]  

  • 7. Why scientists worldwide are watching UK COVID infections.
    Taylor L
    Nature; 2021 Nov; 599(7884):189-190. PubMed ID: 34732879
    [No Abstract]   [Full Text] [Related]  

  • 8. Can immune responses predict which vaccines work best?
    Cohen J
    Science; 2021 Jul; 373(6551):142-143. PubMed ID: 34244387
    [No Abstract]   [Full Text] [Related]  

  • 9. The bumpy road to achieve herd immunity in COVID-19.
    Neagu M
    J Immunoassay Immunochem; 2020 Nov; 41(6):928-945. PubMed ID: 33086932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon.
    McDermott A
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34011611
    [No Abstract]   [Full Text] [Related]  

  • 11. The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?
    Murray CJL; Piot P
    JAMA; 2021 Apr; 325(13):1249-1250. PubMed ID: 33656519
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming.
    Hansen CB; Jarlhelt I; Hasselbalch RB; Hamm SR; Fogh K; Pries-Heje MM; Møller DL; Heftdal LD; Pérez-Alós L; Sørensen E; Larsen MAH; Skjoedt MO; Ostrowski SR; Frikke-Schmidt R; Bayarri-Olmos R; Hilsted LM; Bundgaard H; Nielsen SD; Iversen KK; Garred P
    J Intern Med; 2021 Dec; 290(6):1272-1274. PubMed ID: 34237190
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine.
    Zhou X; Wang H; Ji Q; Du M; Liang Y; Li H; Li F; Shang H; Zhu X; Wang W; Jiang L; Stepanov AV; Ma T; Gong N; Jia X; Gabibov AG; Lou Z; Lu Y; Guo Y; Zhang H; Yang X
    Protein Cell; 2021 Oct; 12(10):818-823. PubMed ID: 33909239
    [No Abstract]   [Full Text] [Related]  

  • 14. Tackling sheepishness about a COVID-19 vaccine for the sake of herd immunity.
    Gildea F
    Perspect Public Health; 2020 Nov; 140(6):301-302. PubMed ID: 33222626
    [No Abstract]   [Full Text] [Related]  

  • 15. Developing Immunity Testing for SARS-CoV-2 and Other Novel Vaccines-Correlates of Immunogenicity Parameters with Protection.
    Vajo Z
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audio Interview: Do We Have the Tools to End the Covid-19 Pandemic?
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Nov; 385(19):e78. PubMed ID: 34731543
    [No Abstract]   [Full Text] [Related]  

  • 17. The dilemma of herd immunity for COVID-19.
    Nejadghaderi SA; Safiri S
    J Med Virol; 2021 May; 93(5):2578-2579. PubMed ID: 33386744
    [No Abstract]   [Full Text] [Related]  

  • 18. China's COVID vaccines have been crucial - now immunity is waning.
    Mallapaty S
    Nature; 2021 Oct; 598(7881):398-399. PubMed ID: 34650240
    [No Abstract]   [Full Text] [Related]  

  • 19. Pfizer COVID vaccine protects against worrying coronavirus variants.
    Callaway E
    Nature; 2021 May; 593(7859):325-326. PubMed ID: 33963317
    [No Abstract]   [Full Text] [Related]  

  • 20. Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines.
    Wang Y
    EBioMedicine; 2021 Nov; 73():103677. PubMed ID: 34742128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.